JaLCDOI | 10.18926/AMO/32678 |
---|---|
FullText URL | fulltext.pdf |
Author | Sakagami, Kenichi| Saito, Shinya| Shiozaki, Shigehiro| Fujiwara, Takuzo| Haisa, Minoru| Niguma, Takefumi| Kusaka, Satoshi| Uda, Masashi| Matsuno, Tsuyoshi| Takasu, Shinji| Yerdel, Mehmet Ali| Matsuoka, Junji| Tanaka, Shinichiro| Orita, Kunzo| |
Abstract | <p>One-hundred-nine HLA-haploidentical living related renal transplants have been retrospectively analysed to compare the effect of donor-specific blood transfusion (DST) and different immunosuppressive regimens on graft survival and acute rejection. The recipients were divided into four groups according to the immunosuppressive therapy. Group 1 (n = 44): conventional therapy with posttransplant azathioprine (AZP) + methylprednisolone (MP). Group 2 (n = 25): pretransplant DST + posttransplant AZP + MP. Group 3 (n = 12): triple-drug therapy with posttransplant AZP + MP + cyclosporine (CS). Group 4 (n = 25): pretransplant DST + posttransplant AZP + MP + CS. The five-year actuarial survival rates for groups 1, 2, 3 and 4 were 48%, 73%, 79%, and 89%, respectively. The graft survival rate in group 3 was significantly (p less than 0.01) better than that in group 1. The transfusion effect was reduced, and appears as a 10% improvement in the graft survival in the cyclosporin era compared with a 25% improvement at pre-cyclosporin era. Furthermore, the incidence of the first rejection episode was decreased in recipients that received DST. The present study revealed that DST, as pretransplant conditioning has a definite impact on rejection-free long-term graft survival in HLA-haploidentical living-related kidney recipients and the most favorable outcome in such patients could be achieved by DST pretreatment in conjunction with posttransplant triple-drug therapy including cyclosporine.</p> |
Keywords | living-related kindney transplantation donor-specific blood transfusion (DST) cyclosporine |
Amo Type | Article |
Published Date | 1992-02 |
Publication Title | Acta Medica Okayama |
Volume | volume46 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 1 |
End Page | 5 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
File Version | publisher |
Refereed | True |
PubMed ID | 1561899 |
Web of Sience KeyUT | A1992HH01700001 |
JaLCDOI | 10.18926/AMO/32032 |
---|---|
FullText URL | fulltext.pdf |
Author | Noguchi, Hirofumi| Naomoto, Yoshio| Haisa, Minoru| Yamatsuji, Tomoki| Shigemitsu, Kaori| Uetsuka, Hirokazu| Hamasaki, Shuji| Tanaka, Noriaki| |
Abstract | <p>A 60-year-old man was admitted to our hospital with a right inguinal swelling that had been growing in size without any pain for 7 months. We diagnosed the growth as a right inguinal hernia and operated on him. The growth, however, was found to be a tumor it situated along the spermatic cord and testicular vessels. We diagnosed it as a lipoma. The tumor was resected near part of the internal inguinal ring. Histopathological diagnosis showed well-differentiated liposarcoma of the sclerosing type. Postoperative computed tomography (CT) revealed a large residual tumor in the retroperitoneum. We believed that the tumor was a retroperitoneal liposarcoma and that it developed in the inguinal region. The residue of the liposarcoma was resected onto the right inguinal tract. A periodic follow up has been performed and no evidence of recurrence or metastasis has been seen in the 4 years and 9 months since the second surgery. No adjuvant therapy was performed. Inguinal liposarcomas are relatively rare and in most cases these tumors are thought to originate in the spermatic cord. The origin of the tumor is believed to be the retroperitoneum</p> |
Keywords | liposarcoma retroperitoneum inguinal hernia |
Amo Type | Article |
Published Date | 2001-02 |
Publication Title | Acta Medica Okayama |
Volume | volume55 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 51 |
End Page | 54 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
File Version | publisher |
Refereed | True |
PubMed ID | 11246977 |
Web of Sience KeyUT | 000167249900007 |